300086 Stock Overview
Honz Pharmaceutical Co., Ltd. engages in the research and development, manufacturing, and sales of pediatric medicines in China.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 3/6 |
Dividends | 0/6 |
Honz Pharmaceutical Co., Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CN¥4.42 |
52 Week High | CN¥7.20 |
52 Week Low | CN¥3.75 |
Beta | 0.73 |
1 Month Change | -15.00% |
3 Month Change | -17.23% |
1 Year Change | -24.06% |
3 Year Change | -33.63% |
5 Year Change | -39.95% |
Change since IPO | -64.88% |
Recent News & Updates
Recent updates
Shareholder Returns
300086 | CN Pharmaceuticals | CN Market | |
---|---|---|---|
7D | -10.3% | -1.5% | -0.4% |
1Y | -24.1% | -16.0% | -17.6% |
Return vs Industry: 300086 underperformed the CN Pharmaceuticals industry which returned -15.9% over the past year.
Return vs Market: 300086 underperformed the CN Market which returned -17.8% over the past year.
Price Volatility
300086 volatility | |
---|---|
300086 Average Weekly Movement | 9.3% |
Pharmaceuticals Industry Average Movement | 7.9% |
Market Average Movement | 8.9% |
10% most volatile stocks in CN Market | 12.7% |
10% least volatile stocks in CN Market | 5.4% |
Stable Share Price: 300086's share price has been volatile over the past 3 months.
Volatility Over Time: 300086's weekly volatility (9%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1993 | 843 | Jiangtao Hong | www.honz.com.cn |
Honz Pharmaceutical Co., Ltd. engages in the research and development, manufacturing, and sales of pediatric medicines in China. The company offers medicines for children and adults in the areas of anti-anaphylaxis, antidiarrheal and digestive, relieving cough, anti-flu, antipyretic, anti-infection, anti-fungal, antipyretic-analgesic, and endocrine; and medical, disposable, and protective face masks. It markets its products through a network of agents and sales terminals.
Honz Pharmaceutical Co., Ltd. Fundamentals Summary
300086 fundamental statistics | |
---|---|
Market cap | CN¥1.99b |
Earnings (TTM) | -CN¥98.43m |
Revenue (TTM) | CN¥638.30m |
3.1x
P/S Ratio-20.2x
P/E RatioIs 300086 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
300086 income statement (TTM) | |
---|---|
Revenue | CN¥638.30m |
Cost of Revenue | CN¥285.07m |
Gross Profit | CN¥353.23m |
Other Expenses | CN¥451.66m |
Earnings | -CN¥98.43m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
Apr 29, 2024
Earnings per share (EPS) | -0.22 |
Gross Margin | 55.34% |
Net Profit Margin | -15.42% |
Debt/Equity Ratio | 34.2% |
How did 300086 perform over the long term?
See historical performance and comparison